View in EDS PDF Full Text

Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer.

Saved in:
Bibliographic Details
Title: Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer.
Authors: Sardela de Miranda F; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Department of Immunology and Molecular Microbiology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States., Castro M; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States., Remmert N; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States., Singh SP; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Department of Internal Medicine, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States., Layeequr Rahman R; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States., Melkus MW; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
Source: Frontiers in immunology [Front Immunol] 2023 Oct 04; Vol. 14, pp. 1258873. Date of Electronic Publication: 2023 Oct 04 (Print Publication: 2023).
Publication Type: Journal Article; Review; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Links:
  – Type: pdflink
Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 37860001
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Sardela+de+Miranda+F%22">Sardela de Miranda F</searchLink>; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Department of Immunology and Molecular Microbiology, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States.<br /><searchLink fieldCode="AU" term="%22Castro+M%22">Castro M</searchLink>; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States.<br /><searchLink fieldCode="AU" term="%22Remmert+N%22">Remmert N</searchLink>; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States.<br /><searchLink fieldCode="AU" term="%22Singh+SP%22">Singh SP</searchLink>; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Department of Internal Medicine, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.<br /><searchLink fieldCode="AU" term="%22Layeequr+Rahman+R%22">Layeequr Rahman R</searchLink>; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States.<br /><searchLink fieldCode="AU" term="%22Melkus+MW%22">Melkus MW</searchLink>; Department of Surgery, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, United States.; Breast Center of Excellence, Texas Tech University Health Sciences Center, Lubbock, TX, United States.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2023 Oct 04; Vol. 14, pp. 1258873. <i>Date of Electronic Publication: </i>2023 Oct 04 (<i>Print Publication: </i>2023).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=37860001
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2023.1258873
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1258873
    Titles:
      – TitleFull: Leveraging cryoablation and checkpoint inhibitors for high-risk triple negative breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Sardela de Miranda F
      – PersonEntity:
          Name:
            NameFull: Castro M
      – PersonEntity:
          Name:
            NameFull: Remmert N
      – PersonEntity:
          Name:
            NameFull: Singh SP
      – PersonEntity:
          Name:
            NameFull: Layeequr Rahman R
      – PersonEntity:
          Name:
            NameFull: Melkus MW
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 04
              M: 10
              Text: 2023 Oct 04
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 14
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1